Cancer Research Grants  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Damania, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Damania, B.
[Cancer Research 66, 3658-3666, April 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Immortalization of Primary Endothelial Cells by the K1 Protein of Kaposi's Sarcoma–Associated Herpesvirus

Ling Wang, Dirk P. Dittmer, Christine C. Tomlinson, Farnaz D. Fakhari and Blossom Damania

Department of Microbiology and Immunology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Requests for reprints: Blossom Damania, Lineberger Comprehensive Cancer Center, University of North Carolina, CB #7295, Chapel Hill, NC 27599. Phone: 919-843-6011; Fax: 425-930-1087; E-mail: damania{at}med.unc.edu.

Kaposi's sarcoma–associated herpesvirus (KSHV) is linked to three different human cancers: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. The Kaposi's sarcoma lesion expresses high levels of angiogenic factors and is comprised of a mixed cell population, including endothelial cells that are infected with KSHV. We find that the KSHV K1 protein is expressed in Kaposi's sarcoma lesions and can immortalize and extend the life span of primary human umbilical vein endothelial cells in culture. Vascular endothelial growth factor (VEGF) is critical for the survival of endothelial cells, and we show that expression of K1 in endothelial cells resulted in increased levels of secreted VEGF and the activation of key signaling pathways, including the VEGF/VEGF receptor and the phosphatidylinositol-3'-OH-kinase (PI3K) pathway. The SH2 binding motifs present in the cytoplasmic tail of K1 were critical for K1's ability to activate these pathways. Activation of PI3K by K1 results in activation of Akt kinase and mammalian target of rapamycin and inactivation of the proapoptotic proteins FKHR, glycogen synthase kinase-3, and Bad, which are events indicative of cell survival. Because activation of the PI3K pathway is critical for transformation of many human cells, we suggest that PI3K activation by K1 is involved in endothelial cell immortalization and contributes to KSHV-associated tumorigenesis. We also report that K1 enhances angiogenesis in vivo and increases tumor vasculature and tumor size. (Cancer Res 2006; 66(7): 3658-66)




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
Z. Berkova, S. Wang, J. F. Wise, H. Maeng, Y. Ji, and F. Samaniego
Mechanism of Fas Signaling Regulation by Human Herpesvirus 8 K1 Oncoprotein
J Natl Cancer Inst, March 18, 2009; 101(6): 399 - 411.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. A. Morris, A. S. Punjabi, and M. Lagunoff
Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells
J. Virol., September 1, 2008; 82(17): 8771 - 8779.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. C. Tomlinson and B. Damania
Critical Role for Endocytosis in the Regulation of Signaling by the Kaposi's Sarcoma-Associated Herpesvirus K1 Protein
J. Virol., July 1, 2008; 82(13): 6514 - 6523.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Wang and B. Damania
Kaposi's Sarcoma-Associated Herpesvirus Confers a Survival Advantage to Endothelial Cells
Cancer Res., June 15, 2008; 68(12): 4640 - 4648.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. E. Huye, S. Ning, M. Kelliher, and J. S. Pagano
Interferon Regulatory Factor 7 Is Activated by a Viral Oncoprotein through RIP-Dependent Ubiquitination
Mol. Cell. Biol., April 15, 2007; 27(8): 2910 - 2918.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. Punjabi, P. A. Carroll, L. Chen, and M. Lagunoff
Persistent Activation of STAT3 by Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells
J. Virol., March 1, 2007; 81(5): 2449 - 2458.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-H. Sin, D. Roy, L. Wang, M. R. Staudt, F. D. Fakhari, D. D. Patel, D. Henry, W. J. Harrington Jr, B. A. Damania, and D. P. Dittmer
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Blood, March 1, 2007; 109(5): 2165 - 2173.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Wang, S. Wang, H. Maeng, D. P. Young, O. Prakash, L. E. Fayad, A. Younes, and F. Samaniego
K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis
Blood, March 1, 2007; 109(5): 2174 - 2182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.